3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1
1
Status
Unknown
1
Recruiting
1
Sponsor Class
INDUSTRY
4
OTHER
2
NIH
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
2
Thoracic
1
Dermatologic
1
Conditions
Melanoma
69
Leukemia, Myeloid, Acute
32
Carcinoma, Renal Cell
27
Neoplasm Metastasis
17
Breast Neoplasms
16
Leukemia
15
Neuroblastoma
14
Kidney Neoplasms
14
Lymphoma, Non-Hodgkin
12
Ovarian Neoplasms
11
Carcinoma, Non-Small-Cell Lung
11
Myelodysplastic Syndromes
10
Recurrence
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Neoplasms
8
Leukemia, Lymphocytic, Chronic, B-Cell
8
Lymphoma
7
Congenital Abnormalities
7
Colorectal Neoplasms
7
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
6
Skin Neoplasms
5
Multiple Myeloma
5
Lymphoma, Mantle-Cell
5
Lymphoma, Follicular
5
Head and Neck Neoplasms
5
Fallopian Tube Neoplasms
5
Carcinoma, Hepatocellular
5
Rectal Neoplasms
4
Mesothelioma, Malignant
4
Lung Neoplasms
4
Interventions
Cisplatin
101
Radiotherapy
53
Brachytherapy
41
Paclitaxel
37
Carboplatin
36
Surveys and Questionnaires
28
Blood Specimen Collection
20
pembrolizumab
19
Radiation
17
Magnetic Resonance Spectroscopy
17
Drug Therapy
17
Colposcopy
16
Bevacizumab
15
Methods
14
Early Intervention, Educational
12
toripalimab
11
Topotecan
11
Radiotherapy, Intensity-Modulated
11
Papanicolaou Test
11
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
11
Chemoradiotherapy
11
Biopsy
11
camrelizumab
10
Mass Screening
10
Gemcitabine
10
Patient Navigation
9
Papillomavirus Vaccines
9
Nivolumab
9
Fluorodeoxyglucose F18
9
Educational Status
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Uterine Cervical Neoplasms
×
Interleukin-2
×
Clear all
NCT06630611
2025-01-28
PragmaTIL
Vall d'Hebron Institute of Oncology
Phase 2
Recruiting
40 enrolled
NCT05895370
2023-06-08
GI-HPVT-01
BGI, China
Phase 1
Unknown
12 enrolled